Novo Nordisk A/S: Diabetes Mellitus, Type 2 trials

The registry lists 633 Diabetes Mellitus, Type 2 studies with Novo Nordisk A/S as lead sponsor. 22 are open to participants now and 175 have results posted.

Phase 1 122Phase 2 37Phase 3 184Phase 4 75No phase 215(a study in two phases counts in both)

Studies

Page 7 of 7. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 DiabetesCompletedNCT00400283Phase 1
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 DiabetesCompletedNCT00399711Phase 3
• Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00383877Phase 3
• Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00348712Phase 3
• Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00343980Phase 3
• Comparison of NovoFine® Needles (4 mm vs. 6 mm)CompletedNCT00343343Phase 2
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00333151Phase 3
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00331851Phase 3
• Safety and Efficacy of Inhaled Insulin in Type 2 DiabetesTerminatedNCT00331604Phase 3
• Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 DiabetesCompletedNCT00318786Phase 3
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00318422Phase 3
• Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.CompletedNCT00313001Phase 3
• Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 DiabetesCompletedNCT00283751Phase 3
• Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 DiabetesCompletedNCT00282451Phase 4
• Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00280046Phase 3
• Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 DiabetesCompletedNCT00274274Phase 4
• Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 DiabetesTerminatedNCT00267683Phase 3
• Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 DiabetesCompletedNCT00264901Phase 4
• Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.CompletedNCT00184626Phase 4
• Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 DiabetesCompletedNCT00184613Phase 1
• Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 DiabetesCompletedNCT00184574Phase 3
• Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 DiabetesCompletedNCT00184561Phase 4
• Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 DiabetesCompletedNCT00154414Phase 2
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00154401Phase 2
• Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and SyringeCompletedNCT00127296Phase 1
• A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion PumpCompletedNCT00115973Phase 1
• Comparison of Insulin Detemir With Insulin Glargine in Type 2 DiabetesCompletedNCT00106366Phase 3
• Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 DiabetesCompletedNCT00104182Phase 3
• INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) StudyCompletedNCT00101751Phase 4
• Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT00097877Phase 3
• Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 DiabetesCompletedNCT00097279Phase 3
• Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 DiabetesCompletedNCT00097084Phase 3
• NovoLog Observation Trial in Subjects With Type 1 and Type 2 DiabetesCompletedNCT00095446Phase 4